Dermatology

Latest News

Tapinarof Cream 1%, Shows Early and Durable Response in Children With Atopic Dermatitis
Tapinarof Cream 1%, Shows Early and Durable Response in Children With Atopic Dermatitis

November 11th 2025

ACAAI 2025. Phase 3 data show tapinarof cream provides early, sustained improvement and good tolerability in children aged ≥2 years with atopic dermatitis.

Treg-Targeting Rezpegaldesleukin Demonstrates Dual Benefit for Asthma and Atopic Dermatitis
Treg-Targeting Rezpegaldesleukin Demonstrates Dual Benefit for Asthma and Atopic Dermatitis

November 10th 2025

FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis: Daily Dose / image credit: ©New Africa/AdobeStock
FDA Approves Guselkumab for Pediatric Plaque Psoriasis, Active Psoriatic Arthritis: Daily Dose

November 7th 2025

5 Novel Mechanisms Reshaping Atopic Dermatitis Treatment / image credit ©designua/stock.adobe.com
5 Novel Mechanisms Reshaping Atopic Dermatitis Treatment and the Phase 2-3 Clinical Trials That Support Them

November 6th 2025

Evidence-Based Management of Papulosquamous Disorders in Primary Care / image credit ©Daniel Beckemeier/stock.adobe.com
Evidence-Based Management of Papulosquamous Disorders in Primary Care

October 7th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.